THE CHOICE OF ANTIDEPRESSANTS FOR THE TREATMENT OF DEPRESSIVE DISORDERS ASSOCIATED WITH EPILEPSY

QR code

THE CHOICE OF ANTIDEPRESSANTS FOR THE TREATMENT OF DEPRESSIVE DISORDERS ASSOCIATED WITH EPILEPSY

The prevalence of depression (D) in patients with epilepsy (PE) is quite high and 12-37% due to common neurobiological structural and morphological and neurotransmitter mechanisms underlying these diseases. Depression negatively affects the quality of life and control of seizures in PE is ass...

Volledige beschrijving

Bewaard in:

Bibliografische gegevens
Hoofdauteurs:	L. V. Lipatova, B. G. Butoma, T. V. Kapustina
Formaat:	Artikel
Taal:	Russisch
Gepubliceerd in:	IRBIS LLC 2016-12-01
Reeks:	Эпилепсия и пароксизмальные состояния
Onderwerpen:	epilepsy depressive disorders antidepressants
Online toegang:	https://www.epilepsia.su/jour/article/view/296
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items

THE SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI) AS TREATMENT OF DEPRESSION IN PATIENTS WITH EPILEPSY
door: Yu. V. Solomatin, et al.
Gepubliceerd in: (2016-12-01)

The Use of Melatoninergic Antidepressants for Stabilization of Remission in Depression Comorbid with Alcohol Abuse, Anxiety or Neuropsychiatric Disorders: A Systematic Review
door: Svetlana G. Klimanova, et al.
Gepubliceerd in: (2024-12-01)

PHARMACOEPIDEMIOLOGICAL MONITORING OF ANTIDEPRESSANT USAGE IN PATIENTS WITH ANXIOUS AND DEPRESSIVE SYNDROMES IN INTERNAL MEDICINE
door: N. V. Ivanova, et al.
Gepubliceerd in: (2015-12-01)

Depressive disorders and their correction in complex treatment of metabolic syndrome patients
door: Yu. P. Uspensky, et al.
Gepubliceerd in: (2007-06-01)

Systematics and principles of therapy for depressive disorders in epilepsy
door: M. V. Usyukina
Gepubliceerd in: (2015-12-01)

Treatment response in relation to subthreshold bipolarity in patients with major depressive disorder receiving antidepressant monotherapy: a post hoc data analysis (KOMDD study)
door: Park Y, et al.
Gepubliceerd in: (2016-05-01)

Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder
door: Harada E, et al.
Gepubliceerd in: (2016-01-01)

THE STRUCTURE OF THE NON-PSYCHOTIC MENTAL (PSYCHIATRIC) DISORDERS IN PATIENTS WITH EPILEPSY WITH DIFFERENT VARIANTS OF THE DISEASE
door: N. A. Sivakova, et al.
Gepubliceerd in: (2017-03-01)

The new molecular targets for antidepressants
door: Yu. V. Kuznetsov, et al.
Gepubliceerd in: (2021-03-01)

Clinical characteristics and efficiency of antidepressant therapy of mood disorders with comorbid alcohol use disorder
door: O. V. Roshchina, et al.
Gepubliceerd in: (2021-07-01)

ACHIEVEMENT OF REMISSION AS A MODERN PURPOSE OF ANTIDEPRESSANT THERAPY
door: O. V. Petrunko
Gepubliceerd in: (2014-11-01)

Anhedonia as a basic syndrome and a target for treatment for depressive disorder
door: G. E. Mazo, et al.
Gepubliceerd in: (2019-10-01)

Symptom networks in major depressive disorder and treatment response: special focus on TRD
door: Alexander Kautzky, et al.
Gepubliceerd in: (2025-01-01)

Role of baseline resting-state functional connectivity of the nucleus accumbens subregions in antidepressant treatment in major depressive disorder
door: Yun Wang, et al.
Gepubliceerd in: (2025-01-01)

EFFICACY OF ANTIHYPERTENSIVE THERAPY WITH ADDED ANTIDEPRESSANT IN HYPERTENSION PATIENTS AND DEPRESSION
door: D. V. Kovalev, et al.
Gepubliceerd in: (2016-06-01)

Pharmacogenetics of Antidepressants: from Genetic Findings to Predictive Strategies
door: L. K. Khokhlov, et al.
Gepubliceerd in: (2019-05-01)

Chronic pain and depression. Correlation and treatment - A review of current literature
door: Barbara Wołoszyn, et al.
Gepubliceerd in: (2025-07-01)

Cognitive profile of patients with depressive disorders and its significance for antidepressant therapy and social functioning
door: K. E. Emelin, et al.
Gepubliceerd in: (2018-07-01)

Medication non-adherence in depression: a systematic review and metanalysis
door: Roseane Dorte Halkjaer-Lassen, et al.
Gepubliceerd in: (2025-07-01)

A heterotrimeric G protein (Gsα) biomarker may predict antidepressant response in subjects with major depressive disorder
door: Steven D. Targum, et al.
Gepubliceerd in: (2025-07-01)

Researches of the imidazole and indole derivatives cerebroprotective activity and its impact on effects of antidepressants
door: I. I. Abramets, et al.
Gepubliceerd in: (2020-07-01)

Bipolar affective disorders in epilepsy
door: G. E. Mazo, et al.
Gepubliceerd in: (2018-07-01)

Use of antidepressants in the treatment of major depressive disorder in primary care during a period of economic crisis
door: Mainar AS, et al.
Gepubliceerd in: (2015-12-01)

COMPLIANCE TO LONG-TERM TREATMENT OF CARDIOLOGIC PATIENTS WITH MILD TO MODERATE DEPRESSION: INEFFECTIVENESS OF ANTIDEPRESSIVE THERAPY WITH PIRLINDOL IN RANDOMIZED STUDY
door: E. V. Strokova, et al.
Gepubliceerd in: (2015-12-01)

AGOMELATINE IN THE TREATMENT OF ANXIETY AND DEPRESSIVE DISORDERS IN PATIENTS WITH ISCHEMIC HEART DISEASE
door: N. Yu. Shimohina, et al.
Gepubliceerd in: (2017-03-01)

Influence of comorbid anxiety and depression disorder on cognition in older adults with epilepsy
door: Hui Qiu, et al.
Gepubliceerd in: (2025-07-01)

Pregestational Stress Representing a Maternal Depression Model and Prenatally Applied Antidepressant Mirtazapine Modulate Hippocampal Excitability in Offspring
door: Lucia Dubiel-Hoppanova, et al.
Gepubliceerd in: (2025-03-01)

Optimizing the diagnosis and treatment of depression in primary care: the emerging role of vortioxetine treatment
door: José Ángel Alcalá, et al.
Gepubliceerd in: (2025-07-01)

Comprehensive Characterization of Antidepressant Pharmacogenetics: A Systematic Review of Studies in Major Depressive Disorder
door: Caroline W. Grant, et al.
Gepubliceerd in: (2025-06-01)

Depression and pain: some issues of comorbidity and treatment (Review)
door: Mamchur V., et al.
Gepubliceerd in: (2011-01-01)

ANXIETY AND DEPRESSION IN INTERNAL MEDICINE
door: A. V. Fedotova
Gepubliceerd in: (2016-01-01)

Possibilities of detecting and correcting decreased heart rate variability in patients with coronary artery disease in combination with depressive disorders in a cardiology department
door: T. G. Nonka, et al.
Gepubliceerd in: (2021-07-01)

Categorical improvements in disease severity in patients with major depressive disorder treated with vilazodone: post hoc analysis of four randomized, placebo-controlled trials
door: Durgam S, et al.
Gepubliceerd in: (2016-12-01)

Medication use patterns, health care resource utilization, and economic burden for patients with major depressive disorder in Beijing, People&rsquo;s Republic of China
door: Zhang L, et al.
Gepubliceerd in: (2016-04-01)

Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
door: Novick D, et al.
Gepubliceerd in: (2016-02-01)

THE FORMATION OF COGNITIVE AND MENTAL DISORDERS IN EPILEPSY: THE ROLE OF VARIOUS FACTORS ASSOCIATED WITH DISEASE AND TREATMENT (A REVIEW OF LITERATURE AND CASE REPORTS)
door: K. Yu. Mukhin, et al.
Gepubliceerd in: (2017-12-01)

CHRONIC DEPRESSIVE DISORDERS
door: O. V. Petrunko
Gepubliceerd in: (2017-04-01)

Cognitive impairments in patients with rheumatoid arthritis and comorbid anxiety and depressive disorders: Outcomes of the five-years prospective study
door: A. A. Abramkin, et al.
Gepubliceerd in: (2024-11-01)

Effect of analgesics, antidepressants and their combinations on changes of structures' of the central nervous system activity in animals with simulated depression
door: Khomiak O.V., et al.
Gepubliceerd in: (2012-01-01)

Insomnia and Esketamine Add-On Therapy to Antidepressant Therapy in Patients with Treatment-Resistant Depression—A Pilot Study
door: Daniel Szawarnoga, et al.
Gepubliceerd in: (2025-07-01)